Joel Batten

Joel Batten is an experienced executive in the pharmaceutical and biotechnology sectors, currently serving as Chief Commercial Officer at 42Bio, Inc. since April 2024, where responsibilities include building and delivering strategic initiatives for the company and its subsidiaries. Previously, Joel held the position of Executive Vice President and General Manager at Veru Inc., overseeing the establishment of the Infectious Disease franchise with a year-one P&L projection of $1B. Joel's career includes significant roles at Sobi - North America, where achievements included exceeding revenue forecasts and successfully managing large teams, along with impactful positions at AstraZeneca and MedImmune that involved public health sales and government affairs. Joel holds a BA in Communications/Public Relations from the University of North Florida.